• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Francis, John P. claimed ownership of 2,611 shares (SEC Form 3)

    1/10/24 4:31:31 PM ET
    $RMED
    Medical/Dental Instruments
    Health Care
    Get the next $RMED alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Francis, John P.

    (Last) (First) (Middle)
    1670 HIGHWAY 160 WEST
    SUITE 205

    (Street)
    FORT MILL SC 29708

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    01/02/2024
    3. Issuer Name and Ticker or Trading Symbol
    Catheter Precision, Inc. [ VTAK ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 2,575 D
    Common Stock 36 I By Spouse
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Series X Convertible Preferred Stock (1) (2) Common Stock 11,481 (3) D
    Warrants (Right to Buy) 05/22/2020 05/22/2025 Common Stock 177 $562.5 I See Footnote 4(4)
    Warrants (Right to Buy) 08/03/2020 08/03/2025 Common Stock 1,371 $437.5 I See footnote 4(4)
    Explanation of Responses:
    1. Security is convertible no earlier than July 9, 2024, subject to satisfaction of specified conditions.
    2. Security has no expiration date.
    3. Security converts at a rate of 1000 shares of common stock per preferred share. Security has no conversion price.
    4. Securities are owned by Catalysis Partners, LLC ("CP"). The reporting person has an investment interest in CP and, together with his spouse, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager.
    /s/ John P. Francis 01/05/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RMED alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $RMED

    DatePrice TargetRatingAnalyst
    10/21/2021$12.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $RMED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jenkins David A bought $9,786 worth of shares (19,056 units at $0.51), increasing direct ownership by 6% to 329,856 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/24/24 4:15:18 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $7,086 worth of shares (16,940 units at $0.42), increasing direct ownership by 6% to 310,800 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/22/24 4:15:35 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $6,323 worth of shares (16,263 units at $0.39), increasing direct ownership by 6% to 293,860 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/18/24 4:15:33 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jenkins David A bought $9,786 worth of shares (19,056 units at $0.51), increasing direct ownership by 6% to 329,856 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/24/24 4:15:18 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $7,086 worth of shares (16,940 units at $0.42), increasing direct ownership by 6% to 310,800 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/22/24 4:15:35 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $6,323 worth of shares (16,263 units at $0.39), increasing direct ownership by 6% to 293,860 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/18/24 4:15:33 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. initiated coverage on Ra Medical Systems with a new price target

      HC Wainwright & Co. initiated coverage of Ra Medical Systems with a rating of Buy and set a new price target of $12.00

      10/21/21 6:17:16 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems downgraded by Maxim Group

      Maxim Group downgraded Ra Medical Systems from Buy to Hold

      3/17/21 8:31:51 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    SEC Filings

    See more
    • Ra Medical Systems Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/25/24 4:15:50 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/11/24 4:15:46 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Inc. filed SEC Form 8-K: Leadership Update

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/4/24 4:20:59 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Reminder: Ra Medical Systems Announces Name and Ticker Symbol Changes

      Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is today, August 17, 2023. The Company has reserved the ticker symbol "VTAK" with the NYSE American, and the Company's common stock is expected to begin trading on the NYSE American under its new name and the new trading symbol effective as of the market open on August 18, 2023. The Company's new website will be unv

      8/17/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Allowance of New Closure Device Patent

      First patent out of six applications on file for LockeT productFORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Entitled "Vessel Closing Device", the patent to be granted is one in a family of six patent applications on file in the US, and in a number of foreign countries, including the European Community, Japan, and China.David Jenkins, interim CEO of Ra Medical Systems, commented, "We are pleased to see the first of what should be several patents to come about with the LockeT closure device. It is a clever design and invention,

      8/14/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division

      Catheter Precision's VIVO System Has Been Utilized in over 1,000 ProceduresFORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure. As a result, VIVO aids in reducing overall procedure time benefitting physicians, hospitals and patients."I made a conscious decision to support a pre-commercial roll out with my own capital. I've invested well over $25mm at an ave

      8/7/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Leadership Updates

    Live Leadership Updates

    See more
    • Ra Medical Systems Announces First Quarter Results

      FORT MILL, SC / ACCESSWIRE / June 2, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced financial and company highlights for the first quarter ended March 31,2023. Among the quarter highlights are the following:RMED concluded the acquisition with the private, company Catheter Precision, Inc. ("Catheter"), in January 2023. Catheter is in the MedTech space of cardiac electrophysiology.Catheter onboarded five direct salespersons and several field clinical persons to assist in the broad US launch of its VIVO product, a product utilized to non-invasively determine the source, or earliest activation, of a ventricular arrhythmia.Catheter introduced to the market its new LockeT closure devi

      6/2/23 6:35:00 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Announces Resignation of CEO

      Board Committee Seeking ReplacementFORT MILL, SC / ACCESSWIRE / April 18, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced today the resignation of its CEO, Will McGuire, for personal reasons. The resignation will be effective April 28, 2023. In conjunction with his resignation as CEO, Mr. McGuire is also resigning from the RMED board of directors. The Company thanks Mr. McGuire for his service and contributions and wishes him the best in future endeavors.The RMED board of directors, as part of its governance commitment, last month established a committee for examining a transition at the CEO level. Mr. David Jenkins, the Company's Executive Chairman of the Board, will serve as Interim

      4/18/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Change in Chief Financial Officer Position Previous Acting CFO Position Replaced with Permanent Appointment

      FORT MILL, SC / ACCESSWIRE / March 30, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced the appointment of Steven Passey as Chief Financial Officer effective April 1, 2023, replacing Brian Conn, who has been serving as Acting Chief Financial Officer."Steven joins the executive team at a pivotal time in Ra Medical's growth", stated Ra Medical's Executive Chairman of the Board David Jenkins. "His background with publicly traded companies, budget and cost control ensures we will maintain the highest standards as a public company. In addition, he is a seasoned executive who has led M&A transactions as well as numerous equity and debt financing transactions for strategic growth. His ex

      3/30/23 7:30:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ra Medical Systems Inc.

      SC 13G - Catheter Precision, Inc. (0001716621) (Subject)

      2/14/24 3:57:22 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Ra Medical Systems Inc. (Amendment)

      SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)

      1/16/24 8:15:49 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Ra Medical Systems Inc.

      SC 13G - Ra Medical Systems, Inc. (0001716621) (Subject)

      3/31/23 4:15:34 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Financials

    Live finance-specific insights

    See more
    • Ra Medical Systems Announces Date of Special Shareholder Meeting

      FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting.Among other items, shareholders are requested to vote in favor of a previously announced $8 million private financing, and to vote in favor of the conversion of RMED preferred stock into common stock, the majority of which will not be converted until mid-2024, at the earliest. The preferred stock was issued in connection with the acquisition of Catheter Precision, Inc., earlier this year.About Ra Medical SystemsRa Medical, and its wholly owned

      2/10/23 9:20:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

      Ra Medical Systems, Inc. (NYSE:RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration   Participants can pre-register for the conference call here:           Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

      5/9/22 6:50:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

      Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides a business update. Recent Operational Highlights Filed 510(k) application with the FDA for our next-generation DABRA catheter that incorporates a braided overjacket designed to improve robustness and includes data supporting a six-month shelf life Enrolled 13 subjects in the company's atherectomy pivotal clinical study since mid-November 2021, for a total of 98 subjects enrolled, and received approv

      3/23/22 4:05:00 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care